Diabetes Devices Market is expected to reach USD 57.15 Billion by 2032, and grow at a CAGR of 7.66%.

The diabetes products market is expanding significantly, driven by several key factors including the rising prevalence of diabetes, technological advancements, increased use of insulin-delivery devices, and escalating obesity rates. These factors are collectively shaping the market and influencing its growth trajectory. Diabetes is becoming a major global health concern. In 2023, it was reported that over 500 million people worldwide are living with diabetes, making it one of the top ten causes of death and disability. The prevalence of diabetes is projected to increase to 6.1% globally, with particularly high rates in North Africa, the Middle East, and Latin America. This rising prevalence underscores the urgent need for effective diabetes management solutions. Technological progress is a significant driver of market growth. Companies are focusing on developing and launching innovative diabetes management products. For example, in 2023, Insulet Corporation acquired Automated Glucose Control LLC, a company specializing in automated insulin delivery technology. This acquisition highlights the emphasis on enhancing diabetes management through advanced technology, which aims to improve patient outcomes and streamline diabetes care.